Disc Medicine, Inc. (IRON) Insider Trading Activity

NASDAQ$81.26+2.35 (2.98%)
Market Cap
$3.03B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
602 of 845
Rank in Industry
350 of 490

IRON Insider Trading Activity

IRON Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$49,931,130
42
100

Related Transactions

Stephenson PamelaChief Commercial Officer
0
$0
1
$347,679
$-347,679
Franchi Jean M.Chief Financial Officer
0
$0
5
$1.2M
$-1.2M
Khara RahulChief Legal Officer
0
$0
6
$1.81M
$-1.81M
Savage William JacobChief Medical Officer
0
$0
4
$2.27M
$-2.27M
Yu Jonathan Yen-WenChief Operating Officer
0
$0
9
$5.59M
$-5.59M
Quisel John DChief Executive Officer
0
$0
5
$12.03M
$-12.03M
Bitterman Kevindirector
0
$0
12
$26.68M
$-26.68M

About Disc Medicine, Inc.

Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.

Insider Activity of Disc Medicine, Inc.

Over the last 12 months, insiders at Disc Medicine, Inc. have bought $0 and sold $49.93M worth of Disc Medicine, Inc. stock.

On average, over the past 5 years, insiders at Disc Medicine, Inc. have bought $12M and sold $43.19M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 222,223 shares for transaction amount of $8M was made by Bitterman Kevin (director) on 2024‑06‑17.

List of Insider Buy and Sell Transactions, Disc Medicine, Inc.

2026-10-21SaleBitterman Kevindirector
25,519
0.0702%
$80.23
$2.05M
+4.48%
2026-10-20SaleBitterman Kevindirector
5,312
0.0139%
$79.95
$424,694
-0.72%
2026-10-19SaleBitterman Kevindirector
10,994
0.029%
$79.97
$879,190
+0.34%
2026-09-11SaleBitterman Kevindirector
27,136
0.0702%
$70.11
$1.9M
-2.25%
2026-09-04SaleBitterman Kevindirector
1,689
0.0044%
$79.96
$135,052
-13.23%
2026-09-03SaleBitterman Kevindirector
5,203
0.0137%
$79.98
$416,136
-13.17%
2026-09-02SaleBitterman Kevindirector
49,164
0.1282%
$80.17
$3.94M
-13.74%
2026-09-01SaleBitterman Kevindirector
129
0.0003%
$79.95
$10,314
-12.06%
2026-08-25SaleYu Jonathan Yen-WenChief Operating Officer
8,796
0.0231%
$83.12
$731,092
-12.51%
2026-08-24SaleYu Jonathan Yen-WenChief Operating Officer
300
0.0008%
$82.53
$24,760
-8.40%
2026-08-17SaleQuisel John DChief Executive Officer
33,000
0.0843%
$79.15
$2.61M
-5.67%
2026-08-12SaleYu Jonathan Yen-WenChief Operating Officer
804
0.0021%
$82.64
$66,445
-5.06%
2026-08-06SaleKhara RahulChief Legal Officer
5,000
0.0135%
$80.00
$400,000
0.00%
2026-07-13SaleQuisel John DChief Executive Officer
33,000
0.0852%
$74.96
$2.47M
+0.22%
2026-07-07SaleYu Jonathan Yen-WenChief Operating Officer
100
0.0003%
$82.50
$8,250
-4.33%
2026-06-29SaleKhara RahulChief Legal Officer
1,649
0.0043%
$75.00
$123,675
+2.40%
2026-06-26SaleYu Jonathan Yen-WenChief Operating Officer
300
0.0008%
$72.50
$21,750
+1.98%
2026-06-22SaleYu Jonathan Yen-WenChief Operating Officer
9,700
0.0261%
$72.66
$704,795
+7.37%
2026-06-18SaleQuisel John DChief Executive Officer
34,000
0.0883%
$70.21
$2.39M
+7.37%
2026-06-18SaleKhara RahulChief Legal Officer
7,500
0.0195%
$70.22
$526,661
+7.37%
Total: 114
*Gray background shows transactions not older than one year

Insider Historical Profitability

33.26%
Quisel John DChief Executive Officer
226064
0.5888%
$17.84M011
Stephenson PamelaChief Commercial Officer
80998
0.211%
$6.39M02
Savage William JacobChief Medical Officer
79480
0.207%
$6.27M012
Franchi Jean M.Chief Financial Officer
64333
0.1676%
$5.08M09
Yu Jonathan Yen-WenChief Operating Officer
54324
0.1415%
$4.29M010
Khara RahulChief Legal Officer
52324
0.1363%
$4.13M09
Bitterman Kevindirector
12991
0.0338%
$1.03M126
+10.7%
AI DMI LLC10 percent owner
3141759
8.1832%
$247.92M10
+100.92%
Atlas Venture Fund X, L.P.10 percent owner
198326
0.5166%
$15.65M07
ORBIMED ADVISORS LLCdirector
186541
0.4859%
$14.72M17
+10.7%
Ashiya Monadirector
186541
0.4859%
$14.72M17
+10.7%
White William Richarddirector
0
0%
$0010
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$52,263,649
70
1.18%
$2.85B
$1,376,668
53
18.46%
$2.8B
$586,486,795
47
4.28%
$2.59B
$61,893,001
38
19.63%
$2.77B
$28,907,358
35
41.41%
$2.66B
$169,745,779
25
31.94%
$3.64B
$137,434,288
25
37.98%
$3.21B
$73,814,940
15
-4.77%
$3.23B
$18,336,420
12
24.03%
$3.63B
$12,644,518
11
20.86%
$3.27B
$1,741,093
10
31.47%
$3.42B
$45,445,266
9
-24.96%
$3.01B
$92,500,325
8
6.45%
$3.37B
$32,575,266
8
37.03%
$3.38B
$955,480
6
-18.91%
$2.83B
Disc Medicine, Inc.
(IRON)
$24,000,085
4
33.26%
$3.03B
$152,517
2
177.13%
$2.53B
$12,272,778
2
117.29%
$2.47B
$9,900,000
1
-7.19%
$3.21B

IRON Institutional Investors: Active Positions

Increased Positions129+94.16%9M+25.77%
Decreased Positions59-43.07%5M-13.8%
New Positions43New3MNew
Sold Out Positions12Sold Out1MSold Out
Total Postitions207+51.09%38M+11.97%

IRON Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Fmr Llc$390,322.0012.99%4.94M+2M+52.05%2025-09-30
Atlas Venture Life Science Advisors, Llc$169,460.005.64%2.14M-241,839-10.14%2025-09-30
Blackrock, Inc.$159,705.005.31%2.02M-25,544-1.25%2025-09-30
Ra Capital Management, L.P.$124,733.004.15%1.58M00%2025-09-30
Vanguard Group Inc$114,527.003.81%1.45M+51,323+3.67%2025-09-30
Frazier Life Sciences Management, L.P.$113,774.003.79%1.44M-216,300-13.07%2025-09-30
Orbimed Advisors Llc$111,914.003.72%1.42M00%2025-09-30
Wellington Management Group Llp$111,523.003.71%1.41M-22,013-1.54%2025-09-30
Price T Rowe Associates Inc /Md/$104,907.003.49%1.33M-189,196-12.48%2025-09-30
State Street Corp$82,696.002.75%1.05M+115,829+12.46%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.